Enhancement of peri-implant bone formation via parathyroid hormone administration in a rat model at risk for medication-related osteonecrosis of the jaw

키워드

참고문헌 (41)

1. Damm DD, "Bisphosphonate-related osteonecrosis of the jaws : a potential alternative to drug holidays", Gen Dent, 61, pp.33~38 (2013)
2. Papapoulos SE, "Bisphosphonates : how do they work", Best Pract Res Clin Endocrinol Metab, 22, pp.831~847 (2008)
3. Marx RE, "Pamidronate(Aredia)and zoledronate(Zometa)induced avascular necrosis of the jaws : a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
4. Ristow O, "Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis", J Oral Maxillofac Surg, 72, pp.903~910 (2014)
5. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)
6. Mücke T, "Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws", J Cancer Res Clin Oncol, 137, pp.907~913 (2011)
7. Stockmann P, "Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw : a prospective clinical study with 12 months follow-up", Support Care Cancer, 18, pp.449~460 (2010)
8. Eckardt AM, "Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients : a challenging problem", Anticancer Res, 31, pp.2313~2318 (2011)
9. Ikeda T, "Successful treatment of bisphosphonate-related osteonecrosis of the jaw(BRONJ)patients with sitafloxacin : new strategies for the treatment of BRONJ", Bone, 73, pp.217~222 (2015)
10. Park JH, "Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw?", J Oral Maxillofac Surg, 75, pp.1176~1184 (2017)
11. Bedogni A, "Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery : a case report and literature review", J Oral Maxillofac Surg, 68, pp.1662~1666 (2010)
12. Tam Y, "Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases", Clin Implant Dent Relat Res, 16, pp.751~761 (2014)
13. Holzinger D, "Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 72, pp.1937.e1~1937.e8 (2014)
14. Nisi M, "Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis", Int J Oral Maxillofac Surg, 44, pp.586~591 (2015)
15. Chadha GK, "Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy : a systematic review", J Oral Implantol, 39, pp.510~520 (2013)
16. Javed F, "Osseointegration of dental implants in patients undergoing bisphosphonate treatment : a literature review", J Periodontol, 81, pp.479~484 (2010)
17. Dayisoylu EH, "The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws : an animal study", Int J Oral Maxillofac Surg, 42, pp.1475~1480 (2013)
18. Ersan N, "Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw : a rat model", Dentomaxillofac Radiol, 43, pp.20130144~ (2014)
19. Keskinruzgar A, "Histopathological effects of teriparatide in medication-related osteonecrosis of the jaw : an animal study", J Oral Maxillofac Surg, 74, pp.68~78 (2016)
20. Doh RM, "Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants", Implant Dent, 24, pp.222~226 (2015)
21. Bashutski JD, "Teriparatide and osseous regeneration in the oral cavity", N Engl J Med, 363, pp.2396~2405 (2010)
22. Compston JE, "Skeletal actions of intermittent parathyroid hormone : effects on bone remodelling and structure", Bone, 40, pp.1447~1452 (2007)
23. Jilka RL, "Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts", Bone, 44, pp.275~286 (2009)
24. "J Oral Maxillofac Surg", 2007, 573~580
25. Narongroeknawin P, "Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report", Spec Care Dentist, 30, pp.77~82 (2010)
26. Sharma D, "Animal models for bisphosphonate-related osteonecrosis of the jaws--an appraisal", Oral Dis, 19, pp.747~754 (2013)
27. Heo HA, "Enhancing effect of intermittent parathyroid hormone administration on bone formation after titanium implant placement in an ovariectomized rat maxilla", Implant Dent, 25, pp.227~231 (2016)
28. Park S, "Intermittent parathyroid hormone improves bone formation around titanium implants in osteoporotic rat maxillae", Int J Oral Maxillofac Implants, 32, pp.204~209 (2017)
29. Fliefel R, "Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw(BRONJ)with characterization of patients : a systematic review", Int J Oral Maxillofac Surg, 44, pp.568~585 (2015)
30. Lazarovici TS, "Bisphosphonate-related osteonecrosis of the jaw associated with dental implants", J Oral Maxillofac Surg, 68, pp.790~796 (2010)
31. Ji-Wan Kim, "Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report", 대한구강악안면외과학회지, 42(3), pp.157~161 (2016), 대한구강악안면외과학회
32. Cardemil C, "The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model", Biomaterials, 34, pp.1546~1561 (2013)
33. López-Jornet P, "An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats", J Oral Pathol Med, 39, pp.697~702 (2010)
34. Hyo Won Jang, "Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)", Maxillofacial Plastic Reconstructive Surgery, 37(7), pp.1~7 (2015), 대한악안면성형재건외과학회[DOI]
35. Dikicier E, "Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats", J Craniomaxillofac Surg, 42, pp.1106~1111 (2014)
36. Yoshiga D, "Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws", Osteoporos Int, 24, pp.2365~2369 (2013)
37. Jilka RL, "Molecular and cellular mechanisms of the anabolic effect of intermittent PTH", Bone, 40, pp.1434~1446 (2007)
38. is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats, "Endocrinology", 2003, 2008~2015
39. Rashid G, "Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor", Eur J Clin Invest, 38, pp.798~803 (2008)
40. Hamada H, "A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography", J Craniomaxillofac Surg, 42, pp.924~929 (2014)
41. Nishida S, "Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow", Bone, 15, pp.717~723 (1994)

관련 논문AI추천